Cargando…

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

Detalles Bibliográficos
Autores principales: Cryer, Byron, Li, Chunming, Simon, Lee S, Singh, Gurkirpal, Stillman, Martin J, Berger, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332426/
http://dx.doi.org/10.1186/ar3664
_version_ 1782230227389251584
author Cryer, Byron
Li, Chunming
Simon, Lee S
Singh, Gurkirpal
Stillman, Martin J
Berger, Manuela
author_facet Cryer, Byron
Li, Chunming
Simon, Lee S
Singh, Gurkirpal
Stillman, Martin J
Berger, Manuela
author_sort Cryer, Byron
collection PubMed
description
format Online
Article
Text
id pubmed-3332426
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33324262012-04-23 GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial Cryer, Byron Li, Chunming Simon, Lee S Singh, Gurkirpal Stillman, Martin J Berger, Manuela Arthritis Res Ther Poster Presentation BioMed Central 2012 2012-02-09 /pmc/articles/PMC3332426/ http://dx.doi.org/10.1186/ar3664 Text en Copyright ©2012 Cryer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Cryer, Byron
Li, Chunming
Simon, Lee S
Singh, Gurkirpal
Stillman, Martin J
Berger, Manuela
GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title_full GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title_fullStr GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title_full_unstemmed GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title_short GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
title_sort gi-reasons: a novel 6-month, prospective, randomized, open-label, blinded end point (probe) trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332426/
http://dx.doi.org/10.1186/ar3664
work_keys_str_mv AT cryerbyron gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial
AT lichunming gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial
AT simonlees gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial
AT singhgurkirpal gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial
AT stillmanmartinj gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial
AT bergermanuela gireasonsanovel6monthprospectiverandomizedopenlabelblindedendpointprobetrial